Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

mTOR Signaling in Parkinson's Disease.

Neuromolecular medicine - 1 Mar 2017

Lan Ai-Ping, Chen Jun, Zhao Yuliang, Chai Zhifang, Hu Yi

Abstract excerpt

As a key regulator of cell metabolism and survival, mechanistic target of rapamycin (mTOR) emerges as a novel therapeutic target for Parkinson's disease (PD). A growing body of research indicates that restoring perturbed mTOR signaling in PD models can prevent neuronal cell death. Nevertheless, molecular mechanisms underlying mTOR-mediated effects in PD have not been fully understood yet. Here, we review recent...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha-Synuclein
Share to Autophagy
Share to Dopaminergic Neurons

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mechanistic Target of Rapamycin Complex 1

Share to Mechanistic Target of Rapamycin Complex 2

Share to Neurotoxins

Share to Parkinsonian Disorders

Share to TOR Serine-Threonine Kinases

Source

Identifiers

PMID: 27263112
DOI: 10.1007/s12017-016-8417-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

mTOR Signaling in Parkinson's Disease.PMID 27263112Read ↗

Molecular neurobiology of mTORSemantic proximity Read ↗

mTOR Mysteries: Nuances and Questions About the Mechanistic Target of Rapamycin in NeurodegenerationSemantic proximity Read ↗

mTOR Signaling in Metabolism and CancerSemantic proximity Read ↗

mTOR signalling: jack-of-all-tradesSemantic proximity Read ↗

mTOR as a central regulator of lifespan and agingSemantic proximity Read ↗

Dysfunction of the mTOR pathway is a risk factor for Alzheimer’s diseaseSemantic proximity Read ↗

mTOR Signaling and Neural Stem Cells: The Tuberous Sclerosis Complex ModelSemantic proximity Read ↗

Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegenerationSemantic proximity Read ↗

mTOR signaling as a molecular target for the alleviation of Alzheimer's disease pathogenesisSemantic proximity Read ↗

Mammalian Target of Rapamycin (mTOR) Signalling Pathway-A Potential Target for Cancer Intervention: A Short OverviewSemantic proximity Read ↗

Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disordersSemantic proximity Read ↗

Dysregulated mTOR-dependent signaling in neurodegeneration or carcinogenesis: implication for Alzheimer's disease and brain tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.